Valeria Ghisetti
Overview
Explore the profile of Valeria Ghisetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
1239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Teodoro G, Siciliano F, Guarrasi V, Vandamme A, Ghisetti V, Sonnerborg A, et al.
Comput Med Imaging Graph
. 2025 Jan;
120:102484.
PMID: 39808870
Predicting the outcome of antiretroviral therapies (ART) for HIV-1 is a pressing clinical challenge, especially when the ART includes drugs with limited effectiveness data. This scarcity of data can arise...
2.
Burdino E, Bernardi A, Cerutti F, Di Vincenzo A, Faraoni S, Gregori G, et al.
Parasitol Int
. 2024 Nov;
104:102988.
PMID: 39510497
Objectives: Chagas disease (CD), or American trypanosomiasis, is a parasitic disease caused by Trypanosoma cruzi, primarily transmitted by triatomine bugs. Increased travels and migrations introduced CD to non-endemic regions, including...
3.
Lazzaro A, Vai D, Barco A, Stroffolini G, Pirriatore V, Guastamacchia G, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
97(2):180-191.
PMID: 39250652
Background: The pathogenesis of HIV-associated neurocognitive (NC) impairment is multifactorial, and antiretroviral (ARV) neurotoxicity may contribute. However, interventional pharmacological studies are limited. Methods: Single-blind, randomized (1:1), controlled trial to assess...
4.
Calcagno A, Tutone M, Del Re S, Delmonte S, Agosta D, Ghisetti V, et al.
Clin Infect Dis
. 2024 Apr;
80(2):476-477.
PMID: 38655679
No abstract available.
5.
Lupia T, Crisa E, Gaviraghi A, Rizzello B, Di Vincenzo A, Carnevale-Schianca F, et al.
Trop Med Infect Dis
. 2023 Jul;
8(7).
PMID: 37505654
and cytomegalovirus co-infections are rarely reported, even though they are distinguished by high morbidity and mortality, especially in immunocompromised hosts. We narratively reviewed the literature on reported cases of and...
6.
Pivetta E, Corcione S, Peasso P, Cara I, Capodanno A, Brussino A, et al.
Antibiotics (Basel)
. 2023 Jun;
12(6).
PMID: 37370274
Bloodstream infections (BSI) are an increasing cause of admissions to hospitals. Non-hospital-acquired BSI are defined by blood cultures that are positive less than 48 hours after admission, but a relevant...
7.
Lupia T, Crisa E, Gaviraghi A, Rizzello B, Di Vincenzo A, Carnevale-Schianca F, et al.
Trop Med Infect Dis
. 2023 Jun;
8(6).
PMID: 37368749
To our knowledge, we have described the first case of /Cytomegalovirus (CMV) concomitant infection that occurred in a European country. The patient was a 76-year-old woman affected by relapsed non-Hodgkin...
8.
Gervais A, Rovida F, Avanzini M, Croce S, Marchal A, Lin S, et al.
J Exp Med
. 2023 Jun;
220(9).
PMID: 37347462
Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for WNV disease...
9.
Trunfio M, Pinnetti C, Arsuffi S, Bai F, Celani L, DEttorre G, et al.
J Med Virol
. 2023 Mar;
95(4):e28704.
PMID: 36967541
Higher risk of cerebrospinal fluid escape (CVE) has been associated with the use of specific antiretroviral (ARV) classes, such as protease inhibitors. We assessed whether archived resistance-associated mutations (RAMs) can...
10.
Carannante A, Vacca P, Fontana S, Dal Conte I, Ghisetti V, Cusini M, et al.
Microb Drug Resist
. 2023 Feb;
29(3):85-95.
PMID: 36757312
The emergence of isolates displaying resistance to antimicrobials, in particular to ceftriaxone monotherapy or ceftriaxone plus azithromycin, represents a global public health concern. This study aimed to analyze the trend...